Indaptus Therapeutics, Inc. (INDP)
INDP Stock Price Chart
Explore Indaptus Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze INDP price movements and trends.
INDP Company Profile
Discover essential business fundamentals and corporate details for Indaptus Therapeutics, Inc. (INDP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Aug 2015
Employees
7.00
Website
https://indaptusrx.comCEO
Jeffrey A. Meckler
Description
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
INDP Financial Timeline
Browse a chronological timeline of Indaptus Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 13 Aug 2025
EPS came in at -$9.09 surpassing the estimated -$9.24 by +1.62%.
Stock split effective on 27 Jun 2025
Shares were split 1 : 28 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2025
EPS came in at -$8.96 surpassing the estimated -$11.48 by +21.95%.
Earnings released on 13 Mar 2025
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%.
Earnings released on 12 Nov 2024
EPS came in at -$0.32 surpassing the estimated -$0.47 by +31.91%.
Earnings released on 12 Aug 2024
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%.
Earnings released on 8 May 2024
EPS came in at -$0.45 surpassing the estimated -$0.57 by +21.05%.
Earnings released on 13 Mar 2024
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%, while revenue for the quarter reached $1.93K .
Earnings released on 6 Nov 2023
EPS came in at -$0.47 surpassing the estimated -$0.55 by +14.55%.
Earnings released on 14 Aug 2023
EPS came in at -$0.39 surpassing the estimated -$0.58 by +32.76%.
Earnings released on 11 May 2023
EPS came in at -$0.51 surpassing the estimated -$0.59 by +13.56%.
Earnings released on 17 Mar 2023
EPS came in at -$0.44 surpassing the estimated -$0.52 by +15.38%.
Earnings released on 10 Nov 2022
EPS came in at -$0.42 surpassing the estimated -$0.47 by +10.64%.
Earnings released on 8 Aug 2022
EPS came in at -$0.46 falling short of the estimated -$0.43 by -6.98%.
Earnings released on 12 May 2022
EPS came in at -$0.41 falling short of the estimated -$0.39 by -5.13%.
Earnings released on 21 Mar 2022
EPS came in at -$0.22 surpassing the estimated -$0.90 by +75.56%.
Earnings released on 15 Nov 2021
EPS came in at -$0.81 falling short of the estimated -$0.55 by -47.27%.
Earnings released on 16 Aug 2021
EPS came in at -$5.53 falling short of the estimated -$2.56 by -116.02%.
Stock split effective on 27 Jul 2021
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 May 2021
EPS came in at -$3.84 falling short of the estimated -$3.48 by -10.34%.
Earnings released on 16 Mar 2021
EPS came in at -$2.12 surpassing the estimated -$3.40 by +37.65%.
Earnings released on 5 Nov 2020
EPS came in at -$3.80 falling short of the estimated -$3.47 by -9.51%.
Stock split effective on 30 Oct 2020
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
INDP Stock Performance
Access detailed INDP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.